Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34734 | 64 | 33.1 | 83% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1650 | 6377 | BICLUSTERING//PROGRAM TRANSLAT IMMUNOVIROL BIODEF//MAYO VACCINE GRP |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DIFFERENTIAL GENE EXPRESSION DETECTION | Author keyword | 3 | 100% | 5% | 3 |
2 | CANCER OUTLIER PROFILE ANALYSIS | Author keyword | 2 | 67% | 3% | 2 |
3 | BREAST CANC DIAG TREATMENT HENAN | Address | 1 | 50% | 2% | 1 |
4 | CHEMOTHERAPY MARKER | Author keyword | 1 | 50% | 2% | 1 |
5 | FISHER LINEAR DISCRIMINANT FUNCTION | Author keyword | 1 | 50% | 2% | 1 |
6 | HETEROGENEOUS DISEASE | Author keyword | 1 | 50% | 2% | 1 |
7 | INTERINDIVIDUAL VARIATION IN GENE EXPRESSION | Author keyword | 1 | 50% | 2% | 1 |
8 | OUTLIER SUM | Author keyword | 1 | 50% | 2% | 1 |
9 | QUALITY TREATMENT | Author keyword | 1 | 50% | 2% | 1 |
10 | STATISTIC METHODOLOGY | Author keyword | 1 | 50% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GENE EXPRESSION DETECTION | 0 | 25% | 2% | 1 |
2 | GENOTYPE CALLS | 0 | 20% | 2% | 1 |
3 | CANCER GENOMICS DATA | 0 | 17% | 2% | 1 |
4 | SUB NETWORK | 0 | 17% | 2% | 1 |
5 | INTEGRIN MEDIATED DEATH | 0 | 100% | 2% | 1 |
Journals |
Reviews |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BREAST CANC DIAG TREATMENT HENAN | 1 | 50% | 1.6% | 1 |
2 | PHPM | 0 | 33% | 1.6% | 1 |
3 | FORENS PATHOL CLIN FORENS MED | 0 | 17% | 3.1% | 2 |
4 | CANC STEM CELL INNOVAT CAST | 0 | 25% | 1.6% | 1 |
5 | GENE VIRAL THER Y | 0 | 13% | 3.1% | 2 |
6 | RONALD A MATRICARIA MOL MED | 0 | 17% | 1.6% | 1 |
7 | ADV COMP DIGITAL ENGN | 0 | 14% | 1.6% | 1 |
8 | MOFFIT CANC | 0 | 13% | 1.6% | 1 |
9 | INEMM | 0 | 11% | 1.6% | 1 |
10 | CANC GENOME DISCOVERY CCGD | 0 | 100% | 1.6% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000181611 | PCA3//TMPRSS2 ERG//PROSTATE CANCER ANTIGEN 3 |
2 | 0.0000179702 | MICROARRAY IMAGE PROCESSING//GENE FILTERING//MAQC |
3 | 0.0000164258 | GENE SET ANALYSIS//ENRICHMENT ANALYSIS//FUNCT GENOM NODE |
4 | 0.0000109484 | GRADE OF MEMBERSHIP ANALYSIS//GRADE OF MEMBERSHIP//OKLAHOMA FAMILY MED |
5 | 0.0000101894 | FALSE DISCOVERY RATE//MULTIPLE TESTING//FAMILYWISE ERROR RATE |
6 | 0.0000097952 | CDK2AP1//DOC 1//P12CDK2 AP1 |
7 | 0.0000080873 | EDGE BIOMARKER//SIBS NOVO NORDISK TRANSLAT PREDIABET//RESP18 |
8 | 0.0000078954 | ONCOTYPE DX//TRIPLE NEGATIVE BREAST CANCER//TRIPLE NEGATIVE |
9 | 0.0000076199 | GYNECOL BREAST//MYOEPITHELIAL CELL LAYER//GYNECOL BREAST PATHOL |
10 | 0.0000067327 | UHRF1//ICBP90//UHRF2 |